[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566301":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":37,"centralContacts":41,"locations":50,"responsibleParty":71,"collaborators":27,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":27,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":82,"minAge":83,"maxAge":27,"enrollmentInfo":84,"targetDuration":27,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":27,"overallStatus":53,"whyStopped":27,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"Icahn School of Medicine at Mount Sinai","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Lidocaine alone","PLACEBO_COMPARATOR","Paracervical block will be performed with just lidocaine",[13,14],"Procedure: paracervical block","Drug: Lidocaine",{"label":16,"type":17,"description":18,"interventionNames":19},"Lidocaine plus ketorolac","EXPERIMENTAL","Paracervical block will be performed with lidocaine plus ketorolac",[13,14,20],"Drug: ketorolac",[22,28,33],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"PROCEDURE","paracervical block","paracervical block with office hysteroscopy",[9,16],null,{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":27},"DRUG","Lidocaine","Dosage: 20 mL of 1% lidocaine",[9,16],{"type":29,"name":34,"description":35,"armGroupLabels":36,"otherNames":27},"ketorolac","Dosage: 2 mL (30 mg) of ketorolac",[16],[38],{"name":39,"affiliation":5,"role":40},"Charles Ascher-Walsh, MD","PRINCIPAL_INVESTIGATOR",[42,47],{"name":43,"role":44,"phone":45,"phoneExt":27,"email":46},"Kathleen E Ackert, DO","CONTACT","212-241-4500","kathleen.ackert@mssm.edu",{"name":48,"role":44,"phone":27,"phoneExt":27,"email":49},"Virginia H Flatow, MD","virginia.flatow@mssm.edu",[51],{"facility":52,"status":53,"city":54,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"Mount Sinai","RECRUITING","New York","10029","United States","US",{"type":59,"coordinates":60},"Point",[61,62],-74.00597,40.71427,{"lat":62,"lon":61},[65,66,68],{"name":39,"role":44,"phone":27,"phoneExt":27,"email":27},{"name":67,"role":44,"phone":27,"phoneExt":27,"email":27},"Virginia Flatow, MD",{"name":69,"role":70,"phone":27,"phoneExt":27,"email":27},"Kathleen E Ackert","SUB_INVESTIGATOR",{"type":40,"investigatorFullName":72,"investigatorTitle":73,"investigatorAffiliation":5,"oldNameTitle":27,"oldOrganization":27},"Charles Ascher-Walsh","Professor","100566301","phase-1-combined-ketorolac-and-lidocaine-paracervical-block-for-office-hysteroscopy-100566301",false,"NCT06653400","Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy","Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy: a Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients assigned female at birth,\n* booked for office hysteroscopy at Mount Sinai Hospital faculty practice associates.\n\nExclusion Criteria:\n\n* Allergy to ketorolac or non-steroidal anti-inflammatory medications\n* Allergy to lidocaine\n* Presence of thrombocytopenia\n* Contraindications to lidocaine\n* History of gastritis or gastric ulcer\n* Acute renal failure or chronic renal disease\n* Chronic liver disease\n* History of bleeding diathesis\n* Long term narcotic use",true,"FEMALE","18 Years",{"count":85,"type":86},60,"ESTIMATED","INTERVENTIONAL",[89],"PHASE1","A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.",[92,93,94],"Abnormal Uterine Bleeding","Analgesia","Paracervical Block","2025-10-29",{"date":97,"type":98},"2025-10-31","ACTUAL",{"date":100,"type":98},"2025-02-27",{"date":102,"type":86},"2026-09-01",{"name":5,"class":6},1]